Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[AIDS--a further development].

T Aoki, Y Taguchi, Y Kaneko

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |May 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pentamidine: a non-peptide GPIIb/IIIa antagonist--in vitro studies on platelets from humans and other species.

    Thrombosis and haemostasis·1992
    Same author

    Nucleotide sequences and characterization of haemolysin genes from Aeromonas hydrophila and Aeromonas sobria.

    Microbial pathogenesis·1992
    Same author

    [Effect of famotidine on gastrin cell, somatostatin cell, and prostaglandin E2 concentration of stomach in experimental pyloric stenosis model].

    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·1992
    Same author

    [The effect of ionized calcium concentration on muscle contraction and on the effect of non-depolarizing neuromuscular blocking agent].

    Masui. The Japanese journal of anesthesiology·1992
    Same author

    Differences in direction-dependent shortening of the left ventricular wall in hypertrophic cardiomyopathy and in systemic hypertension.

    The American journal of cardiology·1992
    Same author

    Effects of modifying agents on conformity of enzyme phenotype and proliferative potential in focal preneoplastic and neoplastic liver cell lesions in rats.

    Japanese journal of cancer research : Gann·1992
    Same journal

    [A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Recent Advances in the Treatment of HER2-Altered Solid Tumors].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [BRAF-Mutant Solid Tumor].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    See all related articles

    This article reviews the biological mechanisms of the human immunodeficiency virus, focusing on how it damages immune cells and the challenges this poses for creating effective treatments and vaccines.

    Area of Science:

    • Immunology and infectious disease research within AIDS medicine
    • Viral pathogenesis and molecular biology

    Background:

    No prior work had fully resolved the complex interplay between viral infection and immune cell dysfunction in early clinical observations. Researchers previously struggled to define how specific viral agents influenced the malignancy and proliferation of immune cells. That uncertainty drove investigations into the distinct roles of different retroviruses in disease progression. It was already known that certain pathogens could alter lymphocyte function, leading to severe health complications. This gap motivated a deeper look into the mechanisms governing viral-induced immune depletion. Prior research has shown that viral envelopes exhibit significant variability, complicating therapeutic efforts. Scientists needed to clarify the distinction between asymptomatic carriers and those exhibiting symptomatic disease manifestations. The current understanding of these viral interactions remains a subject of intense scientific scrutiny.

    Purpose Of The Study:

    The aim of this study is to clarify the biological mechanisms underlying viral-induced immune depletion and disease progression. Researchers sought to resolve the uncertainty surrounding how different retroviruses influence the malignancy of T4 lymphocytes. This investigation addresses the critical need to understand why some individuals remain asymptomatic while others develop complex clinical symptoms. The authors intended to synthesize existing knowledge regarding the structural variability of viral envelopes. They aimed to explain how this diversity contributes to antigenic modulation and challenges in vaccine design. The study also evaluates various therapeutic strategies currently proposed for managing the infection. By examining the interplay between viral function and immune response, the researchers hope to provide a clearer picture of disease pathology. This work serves to consolidate findings on the viral life cycle and its impact on host immunity.

    Keywords:
    viral pathogenesisT4 lymphocytesantigenic modulationreverse transcriptase inhibitors

    Frequently Asked Questions

    The researchers propose that the virus destroys T4 lymphocytes, leading to disease symptoms. When this destructive activity is inhibited, the virus paradoxically promotes the proliferation of these same immune cells, suggesting a complex regulatory role in host cell survival.

    The authors identify the viral envelope as the site containing a diverse array of amino acids. This structural feature results in varied antigenicities, which may facilitate antigenic modulation and hinder the creation of effective preventative vaccines.

    The researchers indicate that blocking the function of the virus is necessary to prevent the depletion of T4 lymphocytes. This intervention is required because the pathogen otherwise induces a functional decline in these cells, which precedes the onset of clinical symptoms.

    Related Experiment Videos

    Main Methods:

    Review approach involved synthesizing clinical data regarding viral pathogenesis and immune cell interaction. Investigators examined the functional impact of specific retroviruses on T4 lymphocyte populations. The analysis focused on identifying how viral proteins influence cell malignancy and proliferation rates. Researchers evaluated the structural properties of viral envelopes to determine their impact on immune recognition. The study assessed various therapeutic modalities reported in the literature for managing viral infections. Experts reviewed evidence concerning the biological distinctions between asymptomatic carriers and symptomatic patients. The methodology prioritized understanding the mechanisms of antigenic modulation in viral evolution. This systematic evaluation provided a framework for categorizing current treatment perspectives and future clinical challenges.

    Main Results:

    Key findings from the literature indicate that the virus directly destroys T4 lymphocytes, causing a functional decline in the immune system. When this destructive mechanism is blocked, the virus triggers an abnormal increase in lymphocyte proliferation. The study identifies a high degree of amino acid variability on the viral envelope, which leads to diverse antigenic profiles. This structural diversity supports the occurrence of antigenic modulation, potentially complicating vaccine efficacy. Researchers confirmed that HTLV-I induces malignant changes and uncontrolled growth in T4 lymphocytes. The literature distinguishes between the clinical status of asymptomatic carriers and patients presenting with complex symptoms. Therapeutic approaches identified include the use of reverse transcriptase inhibitors and direct viral envelope disruption. The evidence suggests that immunopotentiators and bone marrow replacement are also relevant strategies for patient care.

    Conclusions:

    Synthesis and implications suggest that the high variability of viral envelope proteins presents a significant hurdle for vaccine development. The authors propose that antigenic modulation likely contributes to the persistence of the infection. Clinical strategies must account for the diverse ways these pathogens interact with host immune cells. Researchers suggest that blocking reverse transcriptase remains a viable pathway for therapeutic intervention. The study highlights that destroying the virus via its envelope is another potential target for drug design. Replacement of damaged immune cells through bone marrow transplantation is discussed as a possible restorative approach. Immunopotentiators are identified as agents that might assist in stabilizing the patient's immune response. These findings collectively emphasize the multifaceted nature of managing this viral condition.

    The authors utilize clinical observations of viral isolates to characterize the role of antigenic diversity. This data type helps explain why patients exhibit different symptomatic responses and why the virus can evade the host immune system through constant structural changes.

    The researchers observe that HTLV-I induces malignant transformation and abnormal growth in T4 lymphocytes. In contrast, HTLV-III/LAV is characterized by its destructive impact on the same cell population, highlighting distinct pathogenic profiles between these two retroviruses.

    The authors suggest that future therapeutic efforts should focus on multiple fronts, including reverse transcriptase inhibitors and immunopotentiators. They propose that these combined approaches are required to effectively manage the viral load and restore immune function in affected individuals.